Yale Medicine Magazine

We spoke with Nancy J. Brown, MD, the Jean and David W. Wallace Dean of Yale School of Medicine and C.N.H. Long Professor of Internal Medicine, about how Yale School of Medicine researchers and clinicians are advancing discovery, educating students, and breaking down silos to address and prevent chronic disease.

Growing up in Uzbekistan as the Soviet Union crumbled, Ruslan Medzhitov, PhD, was an aspiring biologist whose academic pursuits were nearly derailed by forced labor, military conscription near Chernobyl during its nuclear meltdown, and an attempted coup.

A collection of recent journal publications from Yale School of Medicine researchers.

In a Q&A, Lieping Chen, MD, PhD, discusses his research, immunotherapy, and the future of cancer treatment.

A new type of pain medication is here, delivering treatment without the side effects and potential for addiction that come with opioids.

There's a shift in medicine that’s redefining what it means to treat, cure, and even prevent disease, and it's driven by scientists and clinicians working at the intersection of the human genome, data science, and the clinic.

Glucagon-like peptide-1 (GLP-1) agonists are showing promise for reducing both cardiometabolic disease prevalence and obesity stigma.

Interventional psychiatry is an emerging subspecialty that offers novel treatments for people living with depression. At Yale School of Medicine, researchers collaborate closely with clinicians to accelerate these much-needed advances.

Community-based interventions—in churches, barbershops, and community centers, and more— have emerged as a powerful tool in the fight against hypertension.

Three researchers seek to build on existing work around stroke rehabilitation and are involved in studies they believe will lead to important contributions to long-term outcomes after stroke.